The 2023 Global Culture Report by O.C. Tanner reveals that a poor work-life balance and a lack of staff recognition are key factors driving physical and emotional distress among pharmaceutical industry employees.
For more than 70 years, polymer specialist Raumedic has partnered with companies and practitioners to develop solutions for medical and pharmaceutical applications.
In this MedTalk Podcast episode, Ian Bolland is joined by Lorna Green from LYVA Labs to discuss the latest innovations in pharmaceutical manufacturing, the role of regional investment and accelerator programs, and the challenges faced by life scienc
SCHOTT focuses on possible fill-and-finish solutions based on increased usage of pre-washed and pre-sterilised drug containers compared with traditional filling concepts that work with purchasing non-sterile, so-called ‘bulk’ containers.
MGC Pharmaceuticals' Malta facility has received formal EU-Good Manufacturing Practice (GMP) certification, enabling the production of high-quality plant-inspired medicines such as CannEpil and CimetrA. The large-scale facility can produce over 20
Charles Collins-Chase, partner, and Harry Muttock, associate, at international IP law firm, Finnegan, explore AI’s potential and how companies can use IP to protect their investments in AI technology.
EPM spoke with Nick Porter and Simon Brinckmann, World Courier, about its investment in a real-time location monitoring solution, the unique logistics considerations posed by ATMPs, and World Courier’s expanding geographic footprint.
Erica Cohen, Greenphire, and Thomas Smith, LS public engagement specialist, explore the current issues that hinder rare disease clinical trials, and what solutions should be invested and incorporated to maximise flexibility for the trial patients.
EntityRisk announced that Jeffrey B. Kindler and Frank D’Amelio have led a Series A investment in the company and have been appointed to EntityRisk’s board of directors.
